Alnylam Pharmaceuticals (ALNY) CEO pay: $77.4M actually paid in FY2025
$ALNY · ALNYLAM PHARMACEUTICALS, INC.Data through FY2025 — latest proxy filed 2026-04-06, checked for new filings 2026-08-19. Every number links to its source.
20.0× the tracked-company median CEO pay ($3.9M).
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2020 | Same, peer group since FY2020 | Net income |
|---|---|---|---|---|---|---|
| 2025 | $14.9M | $77.4M | $19.8M | $305.96 | $124.75 | $313.7M |
| 2024 | $11.5M | $29.8M | $7.8M | $204.32 | $118.20 | -$278.2M |
| 2023 | $8.9M | $11.4M | $1.6M | $166.20 | $118.87 | -$440.2M |
| 2022 | $4.6M | $19.0M | $12.6M | $206.35 | $113.65 | -$1.13B |
| 2021 | $10.2M | $17.5M | $10.7M | $147.24 | $126.45 | -$852.8M |
| 2020 | $7.8M | $10.8M | $4.2M | $112.85 | $126.42 | -$858.3M |
Frequently asked
How much did the ALNY CEO make in 2025?
$77,428,521 in Compensation Actually Paid (CAP) as ALNYLAM PHARMACEUTICALS, INC.'s CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2026-04-06.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on ALNY: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary